Shares of Monsanto Company (NYSE:MON) have received an average rating of “Buy” from the twenty-seven brokerages that are covering the firm. Two investment analysts have rated the stock with a sell recommendation, eight have given a hold recommendation and sixteen have given a buy recommendation to the company. The average twelve-month price target among brokerages that have covered the stock in the last year is $114.61.
MON has been the topic of several analyst reports. Vetr raised shares of Monsanto Company from a “hold” rating to a “buy” rating and set a $118.00 price target on the stock in a report on Wednesday, March 15th. CLSA raised shares of Monsanto Company from an “underperform” rating to an “outperform” rating in a report on Friday, January 6th. They noted that the move was a valuation call. Zacks Investment Research raised shares of Monsanto Company from a “strong sell” rating to a “hold” rating in a report on Tuesday, November 29th. Royal Bank of Canada initiated coverage on shares of Monsanto Company in a report on Thursday, February 23rd. They issued a “sector perform” rating and a $118.00 price target on the stock. Finally, Sanford C. Bernstein set a $105.00 price target on shares of Monsanto Company and gave the stock a “neutral” rating in a report on Thursday, January 5th.
var userip;Your IP Address: document.write(userip);
Monsanto Company (NYSE:MON) traded up 0.55% during midday trading on Monday, hitting $113.38. The stock had a trading volume of 1,019,700 shares. The firm has a market capitalization of $49.72 billion, a P/E ratio of 31.09 and a beta of 0.93. Monsanto Company has a 52-week low of $84.79 and a 52-week high of $116.04. The firm has a 50-day moving average of $111.17 and a 200 day moving average of $105.77.
Monsanto Company (NYSE:MON) last released its quarterly earnings results on Thursday, January 5th. The company reported $0.21 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.01 by $0.20. Monsanto Company had a net margin of 11.61% and a return on equity of 47.05%. The business had revenue of $2.22 billion for the quarter. During the same period in the prior year, the firm posted ($0.11) earnings per share. Monsanto Company’s revenue for the quarter was up 19.4% compared to the same quarter last year. On average, equities analysts forecast that Monsanto Company will post $4.74 EPS for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Friday, April 28th. Investors of record on Friday, April 7th will be given a dividend of $0.54 per share. The ex-dividend date of this dividend is Wednesday, April 5th. This represents a $2.16 dividend on an annualized basis and a yield of 1.92%. Monsanto Company’s dividend payout ratio is presently 58.86%.
In other Monsanto Company news, EVP Steven Mizell sold 2,525 shares of the company’s stock in a transaction dated Tuesday, January 10th. The shares were sold at an average price of $108.56, for a total value of $274,114.00. Following the completion of the transaction, the executive vice president now owns 43,711 shares in the company, valued at $4,745,266.16. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, CEO Michael K. Stern sold 5,670 shares of the company’s stock in a transaction dated Wednesday, January 25th. The stock was sold at an average price of $110.00, for a total transaction of $623,700.00. Following the completion of the transaction, the chief executive officer now owns 20,534 shares of the company’s stock, valued at approximately $2,258,740. The disclosure for this sale can be found here. Insiders own 0.79% of the company’s stock.
Hedge funds and other institutional investors have recently modified their holdings of the company. Gould Asset Management LLC CA increased its position in shares of Monsanto Company by 0.5% in the fourth quarter. Gould Asset Management LLC CA now owns 2,750 shares of the company’s stock worth $289,000 after buying an additional 15 shares during the period. Bradley Foster & Sargent Inc. CT increased its position in shares of Monsanto Company by 0.3% in the third quarter. Bradley Foster & Sargent Inc. CT now owns 5,838 shares of the company’s stock worth $597,000 after buying an additional 18 shares during the period. Advisor Partners LLC increased its position in shares of Monsanto Company by 0.4% in the third quarter. Advisor Partners LLC now owns 6,264 shares of the company’s stock worth $640,000 after buying an additional 26 shares during the period. Gerstein Fisher increased its position in shares of Monsanto Company by 0.8% in the third quarter. Gerstein Fisher now owns 4,434 shares of the company’s stock worth $453,000 after buying an additional 37 shares during the period. Finally, Trust Co. of Vermont increased its position in shares of Monsanto Company by 0.8% in the third quarter. Trust Co. of Vermont now owns 4,972 shares of the company’s stock worth $508,000 after buying an additional 40 shares during the period. Institutional investors and hedge funds own 75.18% of the company’s stock.
Monsanto Company Company Profile
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Receive News & Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related companies with MarketBeat.com's FREE daily email newsletter.